Francis MedicalNews Page Francis Medical Receives U.S. FDA Breakthrough Device Designation for Vanquish Minimally Invasive Prostate Cancer Therapy Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water…Casey FrushourAugust 1, 2023
ArboretumNews PagePress Release Arboretum Ventures Exceeds Target with $268 Million Sixth Fund Tom Shehab MD, Jan Garfinkle, Dan Kidle Ann Arbor, MI (June 28, 2023) – Arboretum…Casey FrushourJune 28, 2023
JUMPCODE GenomicsNews Page Element Biosciences and Jumpcode Genomics Partner to Validate Jumpcode’s CRISPRclean® Technology Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a…Casey FrushourFebruary 28, 2022
Health ScholarsNews Page Health Scholars has launched Pediatric Emergency Care™ Pediatric Emergency Care™ will deliver paramedics the immersive practice needed to manage pediatric emergencies in…Casey FrushourFebruary 3, 2022
Koya MedicalNews Page Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…Casey FrushourFebruary 3, 2022
Fifth EyeNews PagePress Release Fifth Eye Receives FDA Clearance to Market AHI System™ Fifth Eye™, a provider of intuitive real-time clinical analytics, today announced the FDA provided clearance…Casey FrushourJanuary 31, 2022
EQRxNews Page EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 18, 2022
EQRxNews Page EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 10, 2022